Skip to main content
Go to homepage

Study of Blood Samples From Newborns With Down Syndrome (AAML08B1)

Study of Blood Samples From Newborns With Down Syndrome

Description:

For complete study information, please view the study on clinicaltrials.gov.

Study Status:
Closed
Full IRB Study Title:
AAML08B1: Biology Study of Transient Myeloproliferative Disorder (TMD) in Children With Down Syndrome (DS)
IRB Study ID:
969979-1
If you are interested in this study or have questions about your child's eligibility, please contact:
Rebecca D. Considine Research Institute, 330-543-3193 or email research@akronchildrens.org
Lead Investigator
Steven Kuerbitz, MD

Director, Divisional Research, Stem Cell Transplantation & Shannon E. Wilkes Targeted Therapy Program; Pediatric Hematologist-Oncologist;
Showers Family Center for Childhood Cancer and Blood DisordersPediatric Stem Cell Transplant Program